Abstract:BACKGROUND AND OBJECTIVE:Due to the synergistic effects of drugs, drug combination is one of the effective approaches for treating complex diseases. However, the identification of drug combinations by dose-response methods is still costly. It is promising to develop supervised learning-based approaches to predict potential drug combinations on a large scale. Nevertheless, these approaches have the inadequate utilization of heterogeneous features, which causes the loss of information useful to classification. Moreover, they have an intrinsic bias, because they assume unknown drug pairs as non-combinations, of which some could be real drug combinations in practice.METHODS:To address above issues, this work first designs a two-layer multiple classifier system (TLMCS) to effectively integrate heterogeneous features involving anatomical therapeutic chemical codes of drugs, drug-drug interactions, drug-target interactions, gene ontology of drug targets, and side effects. To avoid the bias caused by labelling unknown samples as negative, it then utilizes the one-class support vector machines, (which requires no negative instance and only labels approved drug combinations as positive instances), as the member classifiers in TLMCS. Last, both a 10-fold cross validation (10-CV) and a novel prediction are performed to validate the performance of TLMCS.RESULTS:The comparison with three state-of-the-art approaches under 10-CV exhibits the superiority of TLMCS, which achieves the area under the receiver operating characteristic curve = 0.824 and the area under the precision-recall curve = 0.372. Moreover, the experiment under the novel prediction demonstrates its ability, where 9 out of the top-20 predicted combinative drug pairs are validated by checking the published literature. Furthermore, for each of the newly-validated drug combinations, this work analyses the combining mode of the member drugs and investigates their relationship in terms of drug targeting pathways.CONCLUSIONS:The proposed TLMCS provides an effective framework to integrate those heterogeneous features and is trained by only positive samples such that the bias of taking unknown drug pairs as negative samples can be avoided. Furthermore, its results in the novel prediction reveal five types of drug combinations and three types of drug relationships in terms of pathways.

Order-free Medicine Combination Prediction with Graph Convolutional Reinforcement Learning

Medical-Knowledge-Based Graph Neural Network for Medication Combination Prediction.

KAMPNet: multi-source medical knowledge augmented medication prediction network with multi-level graph contrastive learning

Predicting Combinative Drug Pairs Via Multiple Classifier System with Positive Samples Only

A Drug Combination Prediction Framework Based on Graph Convolutional Network and Heterogeneous Information.

Medication Combination Prediction Via Attention Neural Networks with Prior Medical Knowledge

A Complete Graph-Based Approach with Multi-Task Learning for Predicting Synergistic Drug Combinations.

GAMENet: Graph Augmented MEmory Networks for Recommending Medication Combination

Synergistic Multi-Drug Combination Prediction Based on Heterogeneous Network Representation Learning with Contrastive Learning

DRUGSYNC: Prediction of Synergistic Drug Combinations Using GCN Graph Convolutional Network based and Pre-learned Drug-induced Gene Expression Profiles

KnowAugNet: Multi-Source Medical Knowledge Augmented Medication Prediction Network with Multi-Level Graph Contrastive Learning

Accurate prediction of drug combination risk levels based on relational graph convolutional network and multi-head attention

Medication Combination Prediction Using Temporal Attention Mechanism and Simple Graph Convolution

Prediction of Treatment Medicines with Dual Adaptive Sequential Networks

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

LEAP: Learning to Prescribe Effective and Safe Treatment Combinations for Multimorbidity.

Multi-view Contrastive Learning Hypergraph Neural Network for Drug-Microbe-Disease Association Prediction

MGACL: Prediction Drug–Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning

Prediction of Adverse Drug Reactions by Combining Biomedical Tripartite Network and Graph Representation Model.

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

LMGA: Lightweight multi-graph augmentation networks for safe medication recommendation